Effects of acute bupropion administration on locomotor activity in adolescent and adult mice.
Responses to some psychoactive substances seem to differ between adolescents and adults. Bupropion, an antidepressant which is also used for smoking cessation, induces a dose-dependent increase in locomotor activity in adult mice, although its behavioral actions in adolescents have not been evaluated. In the present study the effects of acute bupropion administration (5, 10, 15 and 20 mg/kg) on locomotor activity were examined in early adolescent (postnatal day (pnd): 29-31 days), late adolescent (pnd: 47-49 days) and adult (pnd > 70 days) male NMRI mice, using an infrared photocell system. Locomotion was recorded for a total period of 90 min. Results indicated that there were significant differences in motor activity counts between the three ages evaluated, with late adolescents being more active than early adolescents. Bupropion (at doses 20, 15 and 10 mg/kg) induced a significant increase in locomotion, but there was no significant interaction between age and treatment. This suggests that the locomotor-stimulating effects of bupropion can be observed at different ages (early adolescence, late adolescence and adulthood), although the detailed analysis of the temporal course of locomotion changes induced by different bupropion doses reflected some differences between ages. The lowest dose (5 mg/kg) failed to induce hyperactivity in either adolescent or adult mice.